Pulmonx Corp reported the first quarter of 2026 ended March 31, 2026 results: revenue $20.6 million, net income Net loss in the first quarter of 2026 was $13.7 million, EPS $0.33 per share. Guidance reaffirmed.
“invasive treatments for lung disease, today reported financial results for the first quarter of 2026 ended March 31, 2026. Recent Highlights • Achieved worldwide revenue of $20.6 million in the first quarter of 2026, a 9% decrease over the same period last year and a decrease of 12% on a constant currency basis • Delivered $13.3 million in U.S. revenue in the”
Debt Financings
Pulmonx Corp incurred term loan of up to $60.0 million with Perceptive Credit Holdings V, LP at 7.00% plus the greater of one-month term SOFR and 3.75% maturing March 2, 2031.
“a senior secured term loan facility in an aggregate principal amount of up to $60.0 million”
Material Agreements
Pulmonx Corp entered into Credit Agreement and Guaranty with Perceptive Credit Holdings V, LP valued at up to $60.0 million (effective 2026-03-02).
“On March 2, 2026 (the “Closing Date”), Pulmonx Corporation (the “Company”) entered into a Credit Agreement and Guaranty (the “Credit Agreement”) and a Security Agreement (the “Security Agreement”), with Perceptive Credit Holdings V, LP (“Perceptive”), as the initial lender, administrative agent and collateral agent. The Perceptive Credit Agreement provides for a senior secured term loan facility in an aggregate principal amount of up to $60.0 million (the “Loan Facility”).”
Shareholder Votes
Pulmonx Corp shareholders approved Non-Binding Advisory Vote to Approve the Company's Executive Compensation at the 2024-05-16 meeting.
“Proposal 3 – Non-Binding Advisory Vote to Approve the Company’s Executive Compensation The stockholders approved, on a non-binding advisory basis, the Company’s executive compensation as disclosed in the Proxy Statement. The voting results were as follows: For Against Abstain Broker Non-Votes 16,307,204 14,268,198 8,722 3,802,601”
Shareholder Votes
Pulmonx Corp shareholders approved Ratification of Appointment of Independent Registered Public Accounting Firm at the 2024-05-16 meeting.
“Proposal 2 – Ratification of Appointment of Independent Registered Public Accounting Firm The stockholders ratified the appointment of BDO USA, P.C. as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2024. The voting results were as follows: For Against Abstain 34,338,117 38,937 9,671”
Shareholder Votes
Pulmonx Corp shareholders approved Election of Class I directors at the 2024-05-16 meeting.
“Proposal 1 – Election of Directors The stockholders elected each of the two nominees for Class I director to serve until the Company’s 2027 Annual Meeting of Stockholders and until their successor has been elected and qualified. The voting results were as follows: For Withheld Broker Non-Votes Glendon E. French 16,898,796 13,685,328 3,802,601 Tiffany Sullivan 16,725,724 13,858,350 3,802,601”
Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.